Although, 2-[18F]FDG avidity of BC is related to receptor status (ER, PR, and HER2), tumour grade, and proliferation index (see above), the recommendations given hereafter are valuable for NST BC whatever the BC molecular subtype and the tumour biological characteristics. Here, ERBB2 is linked to breast cancer.